Form 4: Orchestra BioMed Director Eric Fain Sells Shares to Cover Tax Obligations

Director Eric S. Fain of Orchestra BioMed Holdings, Inc. sold shares of common stock between September 6 and September 10, 2024, to cover tax obligations associated with the vesting of restricted stock units.

Summary

• Eric S. Fain, a director of Orchestra BioMed Holdings, Inc., reported the sale of common stock in a Form 4 filing with the SEC.
• The transactions occurred between September 6 and September 10, 2024.
• A total of 5,600 shares were sold indirectly through the Fain Living Trust.
• The sales were executed to cover tax obligations related to the vesting of restricted stock units (RSUs) granted on July 20, 2023.
• The weighted average sale prices ranged from $5.34 to $5.64 per share.
• Following these transactions, the Fain Living Trust beneficially owns 41,210 shares of Orchestra BioMed Holdings, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting share sales by a director to cover tax obligations, which is a neutral event.

Industry Context

Sales of shares by company directors are a common occurrence, often related to compensation or personal financial management. It's important to consider the context of these sales, such as the reason for the sale and the overall holdings of the director.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the context.

Key Dates